The progressive nature of ALS often limits mobility, making regular travel to clinical sites physically exhausting or outright impossible. Many patients require assistance with daily activities and may depend on caregivers, further complicating their ability to attend site-based visits. Home Trial Support (HTS) services can play a pivotal role in addressing these barriers, enhancing accessibility and participation in ALS trials.
